|
Survival By Palliative Treatment』2008년도 대함췌담도학회 춘계학술대회
방성민. 『Best Palliative Management for the Patient with Unresectable Recurrent Biliary Cancer』The Liver Week 2014 1. 정의
2. 원인, 병태생리
3. 증상
4. 검사
5. 치료
6. 합병증
7. 예후
8. 간호
|
|
|
90% 유지
PaO2 60-80 mmHg
O2 1-3L/ min via nasal prongs
7) Surgical therapy(esp. for emphysema)
(1) Bullectomy
(2) Lung volume reduction surgery
(3) Lung transplantation
(single lung transplant - 3 year survival : 75%)
8) Treatment of edema and cor pulmonale
(1) oxygen 투여
(2) small doses of diure
|
|
|
survival rate는 대개 12개월 이내
Treatment result
·overall 5YSR는 73%이고 stage I에서 82%, stage II에서 65%이하.
·surgical stage I에서 5YSR는 grade I에서 95%이상이고, grade III인 stage Ic에서는 75% 미만이었다.
Follow up after treatment
·History taking & Physical exam ; most effecti
|
|
|
Lung cancer :
the most common cause of cancer mortality in the US
28% of all cancer deaths
Peaks between ages 55 and 65 years
5-year survival : 14%
advances in combined-modality treatment with surgery, radiotherapy, and chemotherapy
Etiology
Cigarette smoking(m/i) : with alcohol
Industrial
|
|
|
Treatment
Functional Recovery of the Spinal Cord Injured Model Treated with ADSC
뇌간(brain stem)경색
경추손상 (C7-T1)
Spinal Cord Injury T6-7
Encephalomalacia
간경변
대 머 리
Transplantation of Umbilical-Cord Blood in Babies with Infantile Krabbe's Disease
Survival of the Rats in BMSC I
|
|
 |
), ⑧ Light microscopy. 여기서 4% Formalin (17.5mL)은 PBS 15.75mL과 Formalin 1.75mL를 섞은 것이다.5)
Ⅳ. 연구 결과
Cell treatment를 실시하기 전 상태의 세포를 MTS 염색법으로 염색한 다음 Survival rate를 측정하여 이 값에 대한 상대적 수치로 Paclitaxel 농도조건과
|
|
메뉴펼치기
